On Dec. 15, Gilead Sciences Inc. (NASDAQ:GILD) announced that Philippe C. Bishop, MD, will join the company as Senior Vice President, Hematology and Oncology Therapeutics. In this position, Dr. Bishop will report to John McHutchison, MD, Executive Vice President, Clinical Research and will have responsibility for Gilead’s programs in oncology. Dr. Bishop will also join Gilead’s Executive Committee. Gilead Sciences Inc. (NASDAQ:GILD) belongs to Healthcare sector. Its net profit margin is 45.40% and weekly performance is 4.15%. On last trading day company shares ended up $108.45. Gilead Sciences Inc. (NASDAQ:GILD) distance from 50-day simple moving average (SMA50) is 3.85%.
Zacks lowered shares of Helmerich & Payne (NYSE:HP) from an outperform rating to a neutral rating in a report released on Wednesday. Zacks currently has $64.00 price objective on the stock. Helmerich & Payne, Inc. (NYSE:HP) shares moved up 8.16% in last trading session and ended the day at $71.85. HP Gross Margin is 46.00% and its return on assets is 13.40%. Helmerich & Payne, Inc. (NYSE:HP) quarterly performance is -26.25%.
Five of EBay Inc. (NASDAQ:EBAY)’s top executives will leave the company when it spins off the payment-processing division PayPal next year, and retaining them until the deal closes will cost more than $35 million, according to a regulatory filing. eBay Inc. (NASDAQ:EBAY) belongs to Services sector. Its net profit margin is -0.70% and weekly performance is 2.46%. On last trading day company shares ended up $57.14. eBay Inc. (NASDAQ:EBAY) distance from 50-day simple moving average (SMA50) is 7.04%.
Announced on Dec 12,that Gucci and Coach Inc. (NYSE:COH) upstaged Burberry Group Plc (BRBY) to take the top spot in a study of luxury fashion brands’ digital strategies. Coach, Inc. (NYSE:COH) ended the last trading day at $36.49. Company weekly volatility is calculated as 2.27% and price to cash ratio as 11.08. Coach, Inc. (NYSE:COH) showed a weekly performance of 3.66%.
On Dec. 11, Penford Products, a division of Penford Corporation (NASDAQ:PENX) and a recognized leader in bioproducts innovation and applications development, announced the introduction of PenCare™ DP, a new biobased deposition and conditioning polymer. To support the commercial introduction of PenCare DP, Penford has developed a strategic commercial relationship with exclusive distributor Univar Inc., a leading global chemical distributor of industrial and specialty chemicals. Penford Corporation (NASDAQ:PENX) shares decreased -0.91% in last trading session and ended the day at $18.58. PENX Gross Margin is 12.20% and its return on assets is 3.60%. Penford Corporation (NASDAQ:PENX) quarterly performance is 31.03%.